Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Cash flows from operating activities:
Net income	$ 199,353	$ 296,999
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, depletion and amortization	168,894	133,791
Gain on sale of assets	(1,302)	(1,227)
Impairment	3,919	23,304
Deferred income taxes	26,966	73,923
Net (gain) loss on derivative instruments	27,577	(66,934)
Net (gain) loss from investment in unconsolidated affiliate	(16,296)	2,216
Equity-based compensation expenses	4,771	11,854
Deferred financing costs amortization and other	2,663	(3,791)
Working capital and other changes:
Change in accounts receivable, net	(62,081)	(14,657)
Change in inventory	(9,471)	(12,753)
Change in prepaid expenses	(291)	1,211
Change in accounts payable, interest payable and accrued liabilities	29,147	8,176
Change in other assets and liabilities, net	32,849	16,699
Net cash provided by operating activities	406,698	468,811
Cash flows from investing activities:
Capital expenditures	(222,149)	(172,328)
Acquisitions, net of cash acquired	(334)	0
Proceeds from divestitures, net of cash divested	2,371	7,034
Derivative settlements	(12,062)	(91,656)
Proceeds from sale of investment in unconsolidated affiliate	0	12,347
Contingent consideration received	25,000	0
Distributions from investment in unconsolidated affiliate	2,287	3,015
Net cash used in investing activities	(204,887)	(241,588)
Cash flows from financing activities:
Repurchases of common stock	(31,999)	(15,003)
Tax withholding on vesting of equity-based awards	(46,051)	(10,300)
Dividends paid	(152,389)	(202,473)
Payments on finance lease liabilities	(386)	(388)
Proceeds from warrants exercised	7,370	90
Net cash used in financing activities	(223,455)	(228,074)
Decrease in cash and cash equivalents	(21,644)	(851)
Cash and cash equivalents:
Beginning of period	317,998	593,151	$ 593,151
End of period	296,354	592,300	$ 317,998
Supplemental non-cash transactions:
Change in accrued capital expenditures	25,312	46,097
Change in asset retirement obligations	973	234
Dividends payable	$ 17,587	$ 15,798

Change In Capital Expenditures Incurred But Not Yet Paid

No definition available.

Name:	chrd_ChangeInCapitalExpendituresIncurredButNotYetPaid
Namespace Prefix:	chrd_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The total of the component of interest expense representing the noncash expenses charged against earnings in the period to amortize the long-term deferred financing costs and other income (expense) included in net income that results in no cash inflows or outflows in the period. Includes noncash adjustments to reconcile net income (loss) to cash provided by (used in) operating activities that are not separately disclosed.

+ References

No definition available.